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Dynamic  physiological  and  anatomical  changes  for delivery  may  adversely  induce  various  speciﬁc  non-
obstetric  complications  during  pregnancy  and  puerperal  period.  These  complications  can  be  fatal  to both
the  mother  and  the  fetus,  thus  a precise  and early  diagnosis  ensued  by an  early  treatment  is essential.vailable online 15 June 2015
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Along  with  ultrasonography,  computed  tomography  (CT)  and  magnetic  resonance  imaging  (MRI)  have
assumed  an increasing  role in the  diagnosis.
This article  aims  to  discuss  the  pathophysiology  of these  complications,  the  indications  for  CT and  MRI,
and  the  imaging  ﬁndings.
©  2015  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-NDon-obstetric complications license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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. Introduction
During pregnancy and puerperal period, a dynamic range of
hysiological and physical changes take place in the woman, to
repare her body for delivery. These changes include coagula-
ion, hemodynamic and hormonal changes, as well as changes in
echanical pressure due to an enlarged uterus. Although these sys-
emic changes are not pathologic, they sometimes lead to various
dverse effects. Along with ultrasonography, imaging technologies
uch as computed tomography (CT) and magnetic resonance imag-
ng (MRI) allow for a precise and prompt diagnosis when these
ituations occur. It is thus of prime importance for radiologists to
nderstand the pathophysiology underlying these complications,
he appropriate imaging modalities to employ, and the associated
maging ﬁndings.
In this review, we aim to present the physiological and physical
hanges taking place in women during pregnancy and puerperal
eriod. In addition, we provide an overview of the non-obstetric
omplications arising during pregnancy, with a special focus on CT
nd MRI  ﬁndings and their roles in diagnosis.
. Coagulation system
Pregnancy is a state of hypercoagulability, characterized by
n increase in ﬁbrinogen and coagulation factors and a decrease
f ﬁbrinolytic activity, in preparation for blood loss at delivery.
his hypercoagulability, when combined with other pregnancy-
ssociated physiological and physical changes, may  lead to venous
hromboembolism (VTE) including pulmonary embolism (PE), and
n some cases, acute cerebral infarction.
.1. Venous thromboembolism
Virchow’s triad deﬁnes the risk factors of VTE as the combi-
ation of venous stasis, venous trauma, and hypercoagulability.
hese conditions arise simultaneously and continuously during
regnancy. The incidence is 0.76–1.72:1000 pregnancies [1]. In
omparison to non-pregnant women, the risk of VTE is increased by
-fold during pregnancy and by 60-fold in the ﬁrst 3 months after
elivery.
Approximately 60–80% of VTEs related to pregnancy are deep
enous thrombosis (DVT), the formation of thrombi in large veins.
TE most commonly occurs in the lower limbs, especially in the
eft ﬂank, likely due to compression by the right iliac artery and the
nlarged uterus [1,2]. DVT is reported as the most common cause
f PE, a leading cause of maternal mortality in the developed world
2,3]. The risk of PE is increased by 2-fold during pregnancy and by
p to 30-fold in the ﬁrst 3 months after delivery, most frequently
n the second week [1]. The D-dimer test cannot be used reliably
o exclude PE, as D-dimer levels may  be elevated during pregnancy
associated with untreated PE outweighs by far the risks associ-
ated with fetal radiation exposure, thus it is highly recommended
to immediately perform CT angiography or V/Q scintigraphy in
such cases. On CT angiography, the thrombosis may  be visual-
ized as a low-attenuation ﬁlling defect of the pulmonary arteries,
with or without enlargement (Fig. 1). On V/Q scintigraphy, per-
fusion defects with ventilation–perfusion mismatch are classically
observed. If DVT is found upon US examination, further test-
ing is not necessary because the clinical treatment remains the
same [4].
It is important to state that radiation doses may  be reduced to
a minimum by modifying imaging protocols, but without compro-
mising accuracy [5]. Omitting venography and using lead shielding
around the abdomen upon CT angiography, or omitting the venti-
lation portion in V/Q scintigraphy can help reduce radiation doses
[4].
2.2. Ovarian vein thrombosis and septic pelvic thrombophlebitis
Ovarian vein thrombosis (OVT) complicates 0.5–1.8:1000
deliveries, classically during the postpartum period [6]. Typical
symptoms are fever, lower abdominal pain, and presence of a lower
abdominal mass, representing a thrombosed vein with a surround-
ing phlegmon. OVT is diagnosed on the right ﬂank in 90% of patient
cases. One possible explanation for this right-sided predominance
is the retrograde ﬂow from the left ovarian vein and the antero-
grade ﬂow into the right ovarian vein during the early puerperium,
primarily due to the displacement of the uterus to the right by the
underlying colon [6].
Septic pelvic thrombophlebitis (SPT) is a clinical condition char-
acterized by inﬂammation of pelvic veins with infected thrombosis.
The incidence is documented at 0.3:1000 deliveries, and occursven in the absence of thrombosis. Pulmonary CT angiography or
entilation–perfusion (V/Q) scintigraphy is recommended, when
ower extremity Doppler ultrasonography examination fails to
etect DVT, despite the clinical suspicion of PE. The mortalityFig. 1. Characteristic CT scan showing pulmonary embolism in a woman who  devel-
oped cardiopulmonary arrest 1 day after delivery. Thrombosis crossing the bilateral
pulmonary arteries was  visualized as a defect on contrast-enhanced CT.
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Fig. 2. Characteristic CT scan of septic puerperal ovarian vein thrombosis in a
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soman  presenting high fever after delivery. Thrombosis of the right ovarian vein
as  depicted as a defect on contrast-enhanced CT (arrow). Inﬂammation around the
ein  could also be clearly observed.
ore commonly after a cesarean section than a vaginal delivery [7].
ypical symptoms are a high, spiking fever without severe abdomi-
al pain or sepsis. A continuum between SPT and OVT, arising from
he conditions described in Virchow’s triad, has been suggested [6].
Early recognition is critical because a delayed diagnosis may  lead
o fatal conditions such as PE and sepsis. Color or power Doppler
ltrasonography examination of pelvic veins is the primary imaging
odality used, but may  not be as sensitive as CT or MRI. Contrast
nhanced CT (CECT) venography was reported as the most accu-
ate imaging approach [8]. On CECT, ﬁlling defect within the vein,
hickening blood vessel wall, and the surrounding inﬂammatory
hanges may  be observed (Fig. 2) [8]. Unenhanced CT shows char-
cteristic ﬁndings such as enlarged vein, thrombus with increased
r similar attenuation relative to the wall of the vein. CT is also a use-
ul tool to distinguish these conditions from other complications,
uch as acute appendicitis [9,10]. Contrast enhanced MR  venogra-
hy, including coronal images, can also be employed to visualize
 thrombus and its extension, without the use of radiation [11].
nenhanced MR  venography represents another imaging modal-
ty, especially recommended in prepartum patients in whom the
se of contrast materials is not recommended [12].
.3. Ischemic stroke
Stroke is also a leading cause of maternal mortality. Strokes
an mimic  other more common complications such as eclampsia,
herefore, should be considered whenever neurological deteriora-
ion is observed. Estimates of incidence of stroke associated with
regnancy vary widely in previous reports. The incidence of non-
emorrhagic and hemorrhagic stroke were reported at 18:100,000
nd 8:100,000 pregnancies, respectively [13]. The incidence of fatal
troke is 1.6:100,000 pregnancies [14]. Here, we place the focus on
schemic stroke.
The incidence of ischemic stroke is estimated to increase by
-fold in pregnant women, possibly explained by the state of rela-
ive hypercoagulability [15]. The greatest risk is reported in the 2
ays before and the 1 day period after delivery. Cardio-embolism
s the most commonly reported etiology. CT and MRI are the major
maging modalities in the diagnosis. CT presents the advantages
f availability and rapidness and allows ruling out hemorrhagic
troke, while the major beneﬁts of MRI  are its higher sensitivity,
specially with diffusion weighted imaging (DWI), and the elimi-
ation of radiation exposure (Fig. 3).
In some cases, infarction occurs secondarily to cerebral venous
inus thrombosis (CVST) [13]. The incidence of CVST also increasesFig. 3. MRI scan of ischemic infarction in a woman presenting motor weakness in
the  right arm and leg at 26 gestational weeks. Diffusion-weighted images (DWI)
revealed a left thalamic infarction (arrow).
during pregnancy due to hypercoagulability, most signiﬁcantly in
the ﬁrst 2 weeks of puerperium [16]. CVST should be considered
if an edema or a hemorrhagic lesion crossing arterial territories
is observed. Both CT and MR  venography may  be used as accu-
rate imaging modalities, however the latter may be preferred in
pregnancy-associated CVST, as it eliminates exposure to ionizing
radiation and use of iodinated contrast media [16].
3. Hemodynamic changes
To support the rapidly growing fetus and the placenta, and to
safeguard the mother against blood loss associated with delivery,
the total blood volume begins to increase during the 1st trimester.
Along with an increase in blood volume, there is also a concomi-
tant augmentation in cardiac output and heart rate [17]. Altogether,
these hyperdynamic changes may  lead to various complications,
further discussed below.
3.1. Rupture of brain aneurysm and hemorrhagic stroke
A higher proportion (40%) of hemorrhagic stroke is reported dur-
ing pregnancy, compared to the non-pregnant population (22%)
[18]. A ruptured aneurysm is a common cause of subarachnoid
hemorrhage (SAH), while eclampsia or preeclampsia is often asso-
ciated with intracranial hemorrhage [13,16,18]. It is arguable
whether pregnancy is a risk factor for aneurysmal rupture or not,
but, in general, increased plasma volumes and pregnancy-induced
hypertention account for an increased risk of aneurysmal rupture
[16].
An early and precise diagnosis is critical, and it is highly recom-
mended to perform CT or MRI  on these patients. In general, CT is the
ﬁrst choice to detect hemorrhage, and then MRI  follows. Sometimes
MRI  may  be the ﬁrst method of choice, when exposure to radia-
tion represents an issue. In such cases, ﬂuid-attenuated inversion
recovery (FLAIR) is useful for the detection of SAH, which would fail
to be detected otherwise [19]. MR  angiography is also important to
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Fig. 4. Chest radiograph of acute pulmonary edema in a woman presenting dyspnea
at  26 gestational weeks. The patient was  prescribed with ritodrine hydrochloride
and magnesium sulfate on the basis of cervical incompetency. The chest radiograph
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Fig. 5. MRI  scan of Wernicke’s encephalopathy in a non-pregnant woman pre-
senting alcohol addiction. Axial ﬂuid-attenuated inversion recovery (FLAIR) images
along with hemorrhagic apoplexy, appearing as a dense mass inemonstrated enlargement of the cardiac silhouette, bat wing edema with central
istribution, and spare of the lung cortex. These features completely disappeared
ollowing volume control therapy.
etermine the underlying causes of the hemorrhage, e.g. aneurysm,
oyamoya disease, or arterio-venous malformation, without the
se of contrast material.
.2. Lung edema
In comparison with non-pregnant women, healthy pregnant
omen may  present predisposing factors to lung edema, such as
yperdynamic circulation, physiological anemia and low colloid
smotic pressure. The incidence of acute pulmonary edema is esti-
ated at 0.8:1000 pregnancies, with signiﬁcant maternal mortality.
t occurs most commonly in the antepartum period, closely fol-
owed by the postpartum period. The common causes are the use
f tocolytic agents, especially when multiple tocolytics are used
imultaneously (Fig. 4), cardiac diseases including peripartum car-
iomyopathy, iatrogenic ﬂuid overload, and preeclampsia. In such
ases, chest radiograph is mandatory and typical features includ-
ng upper lobe redistribution, pulmonary inﬁltrates, and Kerley-B
ines should be sought [17]. Transthoracic endocardiography is the
rimary diagnostic and management tool [17].
Keeping this disease and pregnancy-speciﬁc causes in mind
llows for immediate management, avoiding unnecessary exam-
nations such as CT [20].
. Hormonal changes
To develop and maintain an environment favorable to preg-
ancy and to fetal growth, signiﬁcant hormonal changes take place.
he placenta plays an important role in the large-scale production
f a wide variety of pregnancy-related hormones, such as human
horionic gonadotropin (hCG), estrogen, and progesterone. These
ormonal changes alter the endocrine system, which may  in turn
ead to unexpected complications.
.1. Hyperemesis and Wernicke encephalopathyHyperemesis is deﬁned as a severe vomiting disorder resulting
n weight loss, dehydration, alkalosis due to the loss of hydrochloric
cid, and hypokalemia. It is related to high or rapidly rising serum
evels of pregnancy-related hormones.showed symmetrical hyperintense signals around the third ventricle (long arrow)
and the aqueduct of the midbrain (short arrow).
Wernicke’s encephalopathy (WE) is a rare but known compli-
cation of severe hyperemesis gravidarum caused by vitamin B1
deﬁciency. The body’s stored amount of vitamin B1 may be depleted
in only 3 weeks. WE  is a potentially fatal medical emergency and
may result in spontaneous fetal loss [21]. Wernicke’s classic triad
(i.e., confusion, ocular abnormalities and ataxia), is only part of a
wider variety of features, thus, WE  should be suspected whenever
a pregnant patient with persistent vomiting, develops neurologic
alterations [21].
The diagnosis is conﬁrmed on clinical manifestations and rapid
reversal of symptoms with thiamine. MRI  allows for a rapid diag-
nostic conﬁrmation with high speciﬁcity (93%) and moderate
sensitivity (53%) [22]. Typical imaging features include symmet-
rical high intensity in the mesencephalic tegmentum, mammillary
bodies, and medial thalamus on T2-weighted images (T2WI) and
FLAIR (Fig. 5). DWI  may  also depict lesions and allows the distinc-
tion between vasogenic and cytotoxic edema, which is important
to make a prognosis [21].
4.2. Pituitary apoplexy
Pituitary apoplexy is an acute syndrome characterized by
symptoms such as headache, visual deﬁcits, and ophthalmoplegia
associated with an acutely enlarging adenoma caused by hemor-
rhage or infarction. Its incidence increases during pregnancy and
post-partum period, which might be explained by the increased
pituitary stimulation from placental estrogens, the enlargement of
the adenohypophysis, or the rapid growth of tumors, and may  also
result from ischemia [23].
On CT, a heterogeneous sellar/suprasellar mass may  be seenthe acute phase. MRI  depicts an enlarged pituitary with variable T1
and T2 signal intensities, depending on the age of the hemorrhage
(Fig. 6). An apoplexy secondary to infarction may  also be detected
earlier using DWI  [16,24].
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tig. 6. MRI  scan of pituitary hemorrhagic apoplexy in a woman  presenting prolac
omiting. An enlarged pituitary gland was observed with focal hemorrhage, high sig
2-weighted image (B: arrow).
.3. Gallstones and complications
Gallstones and cholecystitis are the second most common non-
bstetric emergency requiring surgery in pregnant patients, after
cute appendicitis [4]. During a normal pregnancy, high levels of
strogen and progesterone may  impair gallbladder motility func-
ion, which increase the incidence of gallstones by up to 12%
25]. Although the incidence of cholecystitis does not increase in
ormal pregnancy, the incidences of both gallstones and chole-
ystitis increase among patients with intrahepatic cholestasis of
regnancy, a rare pregnancy-speciﬁc liver condition. Intrahepatic
holestasis of pregnancy is a disorder characterized by pruritus, ele-
ated serum aminotransferases and bile acid levels with onset in
he second or the third trimester of pregnancy, and a spontaneous
elief occurs within 2–3 weeks after delivery [26].
Ultrasonography is the imaging modality of choice due to its
igh sensitivity and speciﬁcity, however, ultrasonography may  be
imited by the patient’s body habitus, especially in obese patients.
R cholangiopancreatography (MRCP) is the most appropriate
econd-line imaging method, as it is highly sensitive and speciﬁc
or the detection of biliary disease and more sensitive than ultraso-
ography for the detection of choledocholithiasis [4,25]. The stones
ppear indeed as a ﬁlling defect within the high signal bile region.
. Mechanical pressure exerted by an enlarged uterus
During pregnancy, the enlarging uterus leads to the compres-
ion and displacement of other organs. This may thus increase the
isk of speciﬁc complications and sometimes make diagnosis more
ntricate than in non-pregnant patient cases.
.1. Acute appendicitis
Acute appendicitis is the most common non-obstetric emer-
ency requiring surgery during pregnancy. The incidence is
stimated at 1:1700 pregnancies [4], the same as in the non-gravid
opulation.
The diagnosis of acute appendicitis is challenging in the preg-
ant patient because the typical symptoms and clinical ﬁndings
ay  also be present in a normal pregnancy. The displacement of
he appendix by the enlarging uterus also makes the diagnosisa at 34 gestational weeks. The patient also presented symptoms of headache and
ensity on sagittal T1-weighted image (A: arrow) and low signal intensity on sagittal
difﬁcult. Appendiceal rupture is more frequent in pregnant women,
possibly due to the delay in diagnosis and treatment [27], and the
rupture is highly associated with perinatal mortality. Prompt and
accurate diagnosis is therefore critical.
Ultrasonography is classically the ﬁrst imaging method
employed, however, there are limitations including high rates of
indeterminate examinations and dependency on the operator. In
those cases, CT or MRI  should be performed. MRI  is now a well-
established imaging tool for appendicitis in pregnancy with high
sensitivity and speciﬁcity [28]. CT and MRI  ﬁndings will classically
show an appendiceal diameter greater than 7 mm,  increased wall
thickness, ﬂuid collection in the appendix and periappendiceal fat
inﬂammation (Fig. 7) [11,29]. Multiplanar assessments with rapid
sequences such as T2-weighted single-shot fast spin-echo (SSFSE)
images (Fig. 7) and T2WI with fat suppression for detection of peri-
appendiceal inﬂammation are recommended [28].
5.2. Urological disease
Mechanical compression from the enlarged gravid uterus and
smooth muscle relaxation induced by progesterone may  lead to uri-
nary stasis [30]. Altogether, the risk of pyelonephritis is increased
during pregnancy (1–2%) [30,31]. The susceptibility of pregnant
women to urinary tract infection should be kept in mind.
In relation to maternal hydronephrosis, a physiologic
hydronephrosis remains the most common, which may mimic
a pathologic hydronephrosis. It occurs in 60–94% of pregnant
women, usually late in pregnancy, due to ureteral compression by
the gravid uterus, with predominant incidence in the right ﬂank
(80–90%) [4,29]. A physiologic hydronephrosis is characterized by
the smooth tapering of the ureter at the level of the sacral promon-
tory, without pathological causes of obstruction (Fig. 8). On the
other hand, a pathologic hydronephrosis classically presents a
site of obstruction at the pelvoureteral or vesicoureteral junction,
and an abrupt ending of the hydroureter (Fig. 9) [32]. The most
common cause of hydronephrosis during pregnancy is a stone and
the incidence of symptomatic cases is estimated to be 0.5:1000
pregnancies, similar to that of non-pregnant women, with equal
incidence in the right and left ﬂanks [32,33].
The role of imaging is to make the distinction between physio-
logic and pathologic hydronephrosis. Again, ultrasonography is the
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Fig. 7. MRI scan of acute appendicitis in a woman  with right abdominal pain at 28 gestational weeks. Axial (A: arrow) and coronal (B: arrow) single shot ﬁrst spin echo
(SSFSE) images demonstrated ﬂuid collection in the dilated appendix (9 mm),  located at the level of the inferior margin of the liver.
Fig. 8. MRI  scan of physiologic hydronephrosis in a woman presenting right ﬂank pain
(A:  arrow). A dilated right ureter tapered gradually to the level of the sacral promontor
suppression and (B) axial T2-weighted image with fat suppression.
Fig. 9. MRI  scan of pathologic hydronephrosis in a woman presenting left ﬂank
pain at 29 weeks of gestation, and clinically diagnosed with ureteral lithiasis. Left
hydronephrosis and hydroureter at the level of lumbars 3–4 (circle) were observed
on  axial T2-weighted images. The unusual side and site of obstruction suggested a
case  of pathologic hydronephrosis. at 25 weeks of gestation. Right hydronephrosis and hydroureter were observed
y (B: arrow). (A) Coronal single-shot T2-weighted image with breath hold and fat
ﬁrst-line modality, but does not allow depicting the entire ureter,
and the obstructed site often fails to be observed. Transvaginal
ultrasonography is effective to detect stones at the ureterovesi-
cal junction [4]. Unenhanced CT is often the second-line imaging
modality, as it offers high sensitivity in the detection of ureteral
stones, nearing 100%. The implementation of reduced radiation
dose CT protocols may  be adopted without compromising the
accuracy [4]. Alternatively, MR  urography is also a useful imag-
ing tool during pregnancy, as it was  reported to show dilated
ureter, obstructed site, and allowed identiﬁcation of the cause of
the obstruction, thus eliminating exposure to radiation [11,33].
The sensitivity and speciﬁcity of MR  urography in diagnosing
ureteral stones are 77% and 83%, respectively. On  MR  urography
and T2WI, ureteral stones are depicted as ureteral ﬁlling defects.
Care should be taken not to mistake blood, proteins in urine,
ﬂow artifact, ureteral air, or surgical clips for a stone [4,32]. In
a patient with acute obstruction, perirenal and periureteral high
intensity may  be observed on T2WI, which are absent in patients
with chronic obstruction or physiologic hydronephrosis [11]. MRI
also represents a helpful tool to demonstrate complications, such
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aig. 10. MRI scan of red degeneration of uterine leiomyoma in a pregnant woman 
ypointense rim on T2-weighed images (A) and mildly hyperintense signals on T1-
s pyelonephritis, which is visualized as an enlarged edematous
idney [32].
.3. Red degeneration of uterine leiomyoma
During pregnancy, uterine leiomyomas will likely undergo red
egeneration, also known as hemorrhagic infarction, at a rate of
% [34]. It results from the enlargement of the uterus, leading to
lteration of blood supply and ischemia of leiomyomas [29]. Clin-
cal ﬁndings include severe localized abdominal pain, tenderness
n palpation, and sometimes low-grade fever and leukocytosis. The
ondition is often difﬁcult to distinguish from other complications
uch as appendicitis. An accurate diagnosis is important, because
 conservative management is recommended in such cases. MRI
hould be the primary diagnostic tool used, and classical fea-
ures include visualization of the rim characteristic of degenerated
eiomyomas, hyper-intense signals on T1WI and hypo-intense sig-
als on T2WI (Fig. 10) [34].
.4. Ovarian torsion
Ovarian torsion is deﬁned as the partial or complete rotation of
he ovary and its vascular pedicle on the suspensory ligament, with
 right-sided predominance [35]. The incidence rises during preg-
ancy (1:1800), especially in the ﬁrst trimester, when the uterus
ndergoes a rapid increase in size. The most common cause during
ig. 11. MRI scan showing torsion of the right ovary with a corpus luteum cyst in a wom
:  short arrow) and twisted pedicle (A and B: long arrow) were visible. Multiplanar asses
nd  (B) sagittal T2-weighted image.eeks of gestation. The leiomyoma showed a heterogenous signal intensity with a
ted images with fat suppression (B).
pregnancy is a corpus luteum cyst. Torsion of normal ovary may
also be more common in pregnant women  than in non-pregnant
women, owing to ligamentous laxity.
Because tissue necrosis can occur rapidly, a prompt diagno-
sis and treatment are essential to preserve ovarian functions
and healthy pregnancy. Ultrasonography is the ﬁrst-line imag-
ing modality and its features of ovarian torsion include enlarged
adnexal structures and peripheral ovarian lesions [35]. CT and MRI
may  also be performed for conﬁrmation or differentiation of the
diagnosis. MRI  is considered to be more appropriate than CT dur-
ing pregnancy, as this eliminates patient exposure to radiation.
CT and MRI  features include ovarian enlargement (>4.0 cm)  with
or without mass, subacute hemorrhage, twisted pedicle, deviation
of the uterus to the affected side, engorged vessels, and fallopian
tube thickening [35]. On MRI, the enlarged edematous ovary and
its peripheral follicles are clearly observed on T2WI (Fig. 11). On
T1WI with fat saturation, subacute hemorrhage is characterized by
the presence of a hyperintense rim. Multiplanar CT reformations or
MRI  acquisitions are optimal for detection of a twisted pedicle, the
pathognomonic ﬁnding of ovarian torsion [35].
6. Preeclampsia, eclampsia and HELLP syndromePreeclampsia, eclampsia, and HELLP syndrome are multi-
systemic disorders sharing pathogenic, pathologic and clinical
features and result from systemic vascular endothelial damage and
an at 15 gestational weeks. The markedly edematous ovarian parenchyma (A and
sments are optimal for the detection of such ﬁndings. (A) Axial T2-weighted image
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Fig. 12. A woman  with preeclampsia developed HELLP syndrome and hepatic subcapsular hemorrhage 2 days after an emergency cesarean section. A hematoma appeared
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Liver hemorrhage and infarction are rare, but severe and devas-
tating complications of HELLP syndrome. They can also complicate
the pathology of preeclampsia/eclampsia.s  a high density lesion in the subcapsular space on plain CT (A). Streak artifacts due
fter  delivery revealed liver infarction in the peripheral zone of the right lobe and d
asospasm [36]. Diagnosis of these diseases is based on both clini-
al and biochemical criteria. The role of imaging is to diagnose the
ssociated complications and their severity.
Preeclampsia is clinically deﬁned by hypertension and protein-
ria, with or without pathologic edema. Eclampsia is deﬁned by the
nset of convulsions in a woman with preeclampsia that cannot be
ttributed to other causes. HELLP syndrome is clinically described
s the combined occurrence of hemolysis, elevated liver enzyme
evels, and low platelet levels during pregnancy. It is associated
ith a high maternal death rate and important perinatal mortality.
t is believed that vasospasms are the causes of endothelial damage
nd ﬁbrin deposition, followed by accelerated platelet aggregation
nd consumption thrombocytopenia, thrombotic microangiopa-
hy, and hemolytic anemia [36]. It is typically complicated by severe
reeclampsia or eclampsia but can also occur independently [36].
he incidence is approximately 0.1–0.6% of pregnancies, and 4–12%
f patients with severe eclampsia [37]. In many cases (70%), the
ondition is diagnosed antepartum, with 90% of them made after
7 weeks of gestational age. However, it should be kept in mind
hat the remaining 30% are diagnosed postpartum [36].
The common complications associated with the above disorders
nclude hemorrhagic stroke, disseminated intravascular coagula-
ion, acute renal failure, lung edema, hepatic disorders, placental
isorders, posterior reversible encephalopathy syndrome (PRES),
nd so on. Here, we put the emphasis on hepatic disorders and
RES.
.1. Hepatic disorders associated with HELLP syndrome and
reeclampsia
A diseased liver is often associated with devastating conse-
uences, especially in HELLP syndrome. The hepatic pathology
f HELLP syndrome includes focal hepatocyte necrosis, peripor-
al hemorrhage and ﬁbrin deposits in the hepatic sinusoids [36].
n more severe cases, complications such as liver hemorrhage and
nfarction may  also occur. Acute fatty liver of pregnancy (AFLP) has
lso been associated with preeclampsia and HELLP syndrome.
.2. Acute fatty liver of pregnancyAFLP is a rare, but, serious complication usually occurring in
he third trimester of nulliparous patients, with an incidence of
.7–1.0:10,000 pregnancies [38]. Approximately half of the patients
ith AFLP present preeclampsia [39]. arms-down position were visible. Contrast enhanced CT scan (B) obtained 2 weeks
sed density of the subcapsular hematoma.
AFLP is characterized by microvesicular fatty inﬁltration of
hepatocytes without any inﬂammation or necrosis, leading to even-
tual coagulopathy and hypoglycemia secondary to hepatic failure
[38]. AFLP may  result in signiﬁcant perinatal and maternal mortal-
ity. Early diagnosis with immediate termination of pregnancy and
intensive supportive care is essential. Recovery is usually complete,
even after severe hepatic dysfunction.
The diagnostic criteria do not include imaging ﬁndings and
the main role of imaging is to exclude other diseases [19]. Ultra-
sonography might be the ﬁrst-line imaging modality, however,
its sensitivity is low, and the characteristic diffuse increase of
hepatic parenchymal echogenicity is only detected in 20–27% of
the examined patients. Unenhanced CT shows hypo-attenuation
of the hepatic parenchyma in 20–50% of the patients [28]. MRI  is
the most sensitive modality for the detection of cytoplasmic lipids.
The signal dropout is classically observed on opposed-phased T1WI.
MRI  may  be a useful alternative to liver biopsy, which is not rec-
ommended in the current management, due to a high incidence of
coagulopathies in women  with AFLP [40].
6.3. Liver hemorrhage and infarctionFig. 13. A woman presenting preeclampsia developed intracerebral hemorrhage
and  liver infarction, 6 days after an emergency cesarean section. Contrast-enhanced
CT  showed a poorly enhanced geographic area with coursing enhanced vessels in
the posterior segment of the liver.
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Fig. 14. Posterior reversible encephalopathy syndrome (PRES) in a woman presenting eclampsia and HELLP syndrome at 28 weeks of gestation. (A) CT scan at the onset
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[clampsia showing multiple low signal density areas including the bilateral puta
luid-attenuated inversion recovery (FLAIR) images showing multiple hyperintens
fter  treatment.
Imaging ﬁndings of hemorrhage vary depending on the age of
he blood products but are typically manifested as a heterogeneous,
pace-occupying peripheral lesion in the parenchyma or the sub-
apsular space [25]. Although ultrasonography can be performed
apidly without radiation exposure, CT facilitates the characteriza-
ion of hematomas and precise determination of the site and extent
f the intraperitoneal hemorrhage (Fig. 12). CECT shows the intra-
arenchymal hepatic hematomas to be lower in attenuation than
he adjacent liver. When hepatic rupture occurs, CT will show a
ite of focal irregularity with an adjacent sentinel clot or ﬁndings
f remote hemoperitoneum [25].
Imaging ﬁndings of infarction include peripheral geographic
ands of hypoechogenicity upon ultrasonography and decreased
ttenuation upon CT. CECT shows heterogeneous areas of hypo-
ttenuation in a peripheral wedge-shaped pattern, or in a
eographic pattern when the lesions are larger, with enhanced
essels coursing through these areas (Fig. 13). In MRI, the corre-
ponding areas are depicted as mildly high intensity on T2WI and
ow intensity on T1WI [25].
.4. Posterior reversible encephalopathy syndrome (PRES)
PRES is a clinically recognizable entity presenting features
uch as headache, altered consciousness, visual abnormalities,
nd seizures in conjunction with the neuroimaging ﬁndings of
asogenic edema, typically involving the posterior circulation.
his condition is likely induced by endothelial dysfunction lead-
ng to increased permeability [16]. Several studies have shown
hat neurological imaging ﬁndings consistent with PRES were
resent in many patients with severe preeclampsia/eclampsia
41–43].
A typical MRI  ﬁnding associated with PRES is hyperintensity of
he parieto-occipital cortices and subcortical white matter on T2WI
nd FLAIR images, usually indicating vasogenic edema (Fig. 14B).
he posterior frontal and inferior temporal regions, and less com-
only the brainstem, basal ganglia, and cerebellum, are involved.
he lesions rarely demonstrate contrast enhancement, hemor-
hage, or restricted diffusion. Unenhanced CT might be performed
t ﬁrst to exclude hemorrhagic stroke. The lesions are classically
epicted as low density area (Fig. 14A) [16]. Less severe edema,
ytotoxic edema, hemorrhage, and contrast enhancement have
een reported. In follow-up MRI, more frequent complete resolu-
ions of edema were observed [44].
[external capsule, thalami and left occipital lobe. The pons was also involved. (B)
ons/spots, which completely disappeared in the follow-up images taken 1 month
7. Conclusion
The dynamic changes occurring during pregnancy may  induce a
variety of non-obstetric complications affecting organs from head
to toe. A deep understanding of the imaging ﬁndings associated
with these various conditions and their pathophysiological rele-
vance to pregnancy will allow a more precise and early diagnosis,
ensued by an early treatment.
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